血浆醛固酮与肾素比值与新诊断高血压患者降压治疗血压反应的关系
这项在基层医疗开展的前瞻性队列研究纳入304例新诊断高血压患者,在治疗前测定血浆醛固酮与肾素比值(ARR),分析其与1年内血压反应的关系。结果显示ARR与血压反应及达标(收缩压<140 mmHg)均无关联,各治疗组结果一致。
要点
- 新诊断高血压患者治疗前ARR与1年内血压反应无关。
- ARR与收缩压<140 mmHg达标无关联(OR 1.002,95%CI 0.983-1.022)。
- 各降压药物组中ARR与血压反应的关系均无统计学关联。
核心结论
- 在基层医疗新诊断高血压患者中,治疗前ARR与1年内降压治疗的血压反应无关联。
研究设计与样本
- 前瞻性队列研究,在基层医疗纳入304例新诊断高血压患者,治疗前测定ARR,分析947次测量(727次未用药,220次用药)与1年内血压反应的关系。
主要发现
- ARR与血压反应无关联,且这一结果适用于每个治疗组。
- 31%的患者达到目标血压(收缩压<140 mmHg)。
- ARR与达到目标血压无关联(OR 1.002,95%CI 0.983-1.022)。
关键数值与推荐
- 目标血压定义为收缩压<140 mmHg,31%的患者达到该目标。
- ARR与达标关联的OR为1.002(95%CI 0.983-1.022)。
临床怎么用
- 基层医生在新诊断高血压患者中不宜依据ARR预测1年内降压治疗的血压反应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Individualized antihypertensive treatment based on specific biomarkers such as renin may lead to more effective blood pressure control in patients with newly diagnosed essential hypertension. Recent studies suggested that the plasma aldosterone-to-renin ratio (ARR) may also be a candidate predictor for this purpose. OBJECTIVE: To assess whether the ARR is associated with the blood pressure response to antihypertensive treatment in patients with newly diagnosed hypertension. METHODS: In this prospective cohort study in primary care, we determined the ARR in patients with newly diagnosed hypertension prior to starting treatment. Treatment was categorized in five groups: no medication, use of angiotensin-converting-enzyme inhibitor or angiotensin receptor blocker, use of calcium channel blocker, use of diuretic, or use of beta blocker. We examined the relation between the ARR and blood pressure response within 1 year of treatment, taking into account the type of antihypertensive treatment and adjusting for gender, age, baseline blood pressure, and comorbidity. RESULTS: Out of 304 patients, we used 947 measurements (727 no medication, 220 medication) for analysis. There was no association between the ARR and the response in blood pressure, and this applied to each treatment group. Target blood pressure, defined as systolic blood pressure <140 mmHg, was reached in 31% of patients. There was no association between the ARR and reaching target blood pressure (OR 1.002, 95% CI 0.983-1.022). CONCLUSION: The ARR is not associated with the response in blood pressure within 1 year of antihypertensive treatment in primary care.
引用
- Käyser SC, Schalk BWM, de Grauw WJC, et al. Is the plasma aldosterone-to-renin ratio associated with blood pressure response to treatment in general practice? Fam Pract. 2019. PMID: 29788258. doi:10.1093/fampra/cmy039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。